On ECHEMI
Home > Drugs > Klebsiella pneumoniae pneumonia
Klebsiella pneumoniae pneumonia
Klebsiella pneumoniae, also known as pneumonia bacillus or Friedlander bacillus, is the first Gram-negative bacillus known to cause pneumonia. In the past two or three decades, with the changes in susceptible populations, the widespread use of antimicrobial drugs and the evolution of drug-resistant bacteria, as well as the improvement and popularization of various microbial detection technologies, GNBP has become an important disease in modern medicine in the antibiotic era.
  • Site of disease:

    lung
  • Infectious :

    Not contagious
  • Frequent population:

    Middle-aged and elderly people
  • Related symptoms:

    High fever chest pain cough chills leukocytosis
  • Concurrent disease:

Related Drugs
Amikacin Sulfate Injection
Indication: This product is suitable for serious infections caused by sensitive Gram-negative bacteria such as Pseudomonas aeruginosa and other Pseudomonas, Escherichia coli, Proteus, Klebsiella, Enterobacter, Serratia, Acinetobacter, and Staphylococcus (methicillin-sensitive strains), such as bacteremia or sepsis, bacterial endocarditis, lower respiratory tract infection, bone and joint infection, biliary tract infection, abdominal infection, complicated urinary tract infection, skin and soft tissue infection, etc. Since this product is stable to most aminoglycoside inactivating enzymes, it is particularly suitable for the treatment of serious infections caused by Gram-negative bacteria resistant to kanamycin, gentamicin or tobramycin.
Manufacturer:

Shanghai Harvest Pharmaceutical Co., Ltd.

Amikacin Sulfate Injection
Indication: This product is suitable for serious infections caused by sensitive Gram-negative bacteria such as Pseudomonas aeruginosa and other Pseudomonas, Escherichia coli, Proteus, Klebsiella, Enterobacter, Serratia, Acinetobacter, and Staphylococcus (methicillin-sensitive strains), such as bacteremia or sepsis, bacterial endocarditis, lower respiratory tract infection, bone and joint infection, biliary tract infection, abdominal infection, complicated urinary tract infection, skin and soft tissue infection, etc. Since this product is stable to most aminoglycoside inactivating enzymes, it is particularly suitable for the treatment of serious infections caused by Gram-negative bacteria resistant to kanamycin, gentamicin or tobramycin.
Manufacturer:

Qilu Pharmaceutical Co., Ltd.

Amikacin Sulfate Injection
Indication: This product is suitable for serious infections caused by sensitive Gram-negative bacteria such as Pseudomonas aeruginosa and other Pseudomonas, Escherichia coli, Proteus, Klebsiella, Enterobacter, Serratia, Acinetobacter, and Staphylococcus (methicillin-sensitive strains), such as bacteremia or sepsis, bacterial endocarditis, lower respiratory tract infection, bone and joint infection, biliary tract infection, abdominal infection, complicated urinary tract infection, skin and soft tissue infection, etc. Since this product is stable to most aminoglycoside inactivating enzymes, it is particularly suitable for the treatment of serious infections caused by Gram-negative bacteria resistant to kanamycin, gentamicin or tobramycin.
Manufacturer:

Sinopharm Ronshyn Pharmaceutical Co., Ltd.

Amikacin Sulfate Injection
Indication: This product is suitable for serious infections caused by sensitive Gram-negative bacteria such as Pseudomonas aeruginosa and other Pseudomonas, Escherichia coli, Proteus, Klebsiella, Enterobacter, Serratia, Acinetobacter, and Staphylococcus (methicillin-sensitive strains), such as bacteremia or sepsis, bacterial endocarditis, lower respiratory tract infection, bone and joint infection, biliary tract infection, abdominal infection, complicated urinary tract infection, skin and soft tissue infection, etc. Since this product is stable to most aminoglycoside inactivating enzymes, it is particularly suitable for the treatment of serious infections caused by Gram-negative bacteria resistant to kanamycin, gentamicin or tobramycin.
Manufacturer:

Yichang Humanwell Pharmaceutical Co., Ltd.

Amikacin Sulfate Injection
Indication: This product is suitable for serious infections caused by sensitive Gram-negative bacteria such as Pseudomonas aeruginosa and other Pseudomonas, Escherichia coli, Proteus, Klebsiella, Enterobacter, Serratia, Acinetobacter, and Staphylococcus (methicillin-sensitive strains), such as bacteremia or sepsis, bacterial endocarditis, lower respiratory tract infection, bone and joint infection, biliary tract infection, abdominal infection, complicated urinary tract infection, skin and soft tissue infection, etc. Since this product is stable to most aminoglycoside inactivating enzymes, it is particularly suitable for the treatment of serious infections caused by Gram-negative bacteria resistant to kanamycin, gentamicin or tobramycin.
Manufacturer:

Shanghai Xudong Haipu Pharmaceutical Co., Ltd.

Amikacin Sulfate Injection
Indication: This product is suitable for serious infections caused by sensitive Gram-negative bacteria such as Pseudomonas aeruginosa and other Pseudomonas, Escherichia coli, Proteus, Klebsiella, Enterobacter, Serratia, Acinetobacter, and Staphylococcus (methicillin-sensitive strains), such as bacteremia or sepsis, bacterial endocarditis, lower respiratory tract infection, bone and joint infection, biliary tract infection, abdominal infection, complicated urinary tract infection, skin and soft tissue infection, etc. Since this product is stable to most aminoglycoside inactivating enzymes, it is particularly suitable for the treatment of serious infections caused by Gram-negative bacteria resistant to kanamycin, gentamicin or tobramycin.
Manufacturer:

Shanghai Fuda Pharmaceutical Co., Ltd.

Amikacin Sulfate Sodium Chloride Injection
Indication: This product is suitable for serious infections caused by Pseudomonas aeruginosa and some other Pseudomonas, Escherichia coli, Proteus, Klebsiella, Enterobacter, Serratia, Acinetobacter and other sensitive Gram-negative rods and Staphylococcus (methicillin-sensitive strains), such as bacteremia or sepsis, bacterial endocarditis, lower respiratory tract infection, bone and joint infection, biliary tract infection, abdominal infection, complicated urinary tract infection, skin and soft tissue infection, etc. Since this product is stable to most aminoglycoside inactivating enzymes, it is particularly suitable for the treatment of serious infections caused by Gram-negative rods resistant to kanamycin, gentamicin or tobramycin.
Manufacturer:

Yangtze River Pharmaceutical (Group) Co., Ltd.

Amikacin Sulfate Injection
Indication: This product is suitable for serious infections caused by Pseudomonas aeruginosa and some other Pseudomonas, Escherichia coli, Proteus, Klebsiella, Enterobacter, Serratia, Acinetobacter and other sensitive Gram-negative rods and Staphylococcus (methicillin-sensitive strains), such as bacteremia or sepsis, bacterial endocarditis, lower respiratory tract infection, bone and joint infection, biliary tract infection, abdominal infection, complicated urinary tract infection, skin and soft tissue infection, etc. Since this product is stable to most aminoglycoside inactivating enzymes, it is particularly suitable for the treatment of serious infections caused by Gram-negative rods resistant to kanamycin, gentamicin or tobramycin.
Manufacturer:

Zhejiang Conba Pharmaceutical Co., Ltd.

Amikacin Sulfate Injection
Indication: This product is suitable for serious infections caused by sensitive Gram-negative bacilli such as Pseudomonas aeruginosa and other Pseudomonas, Escherichia coli, Proteus, Klebsiella, Enterobacter, Serratia, Acinetobacter, and Staphylococcus (methicillin-sensitive strains), such as bacteremia or sepsis, bacterial endocarditis, lower respiratory tract infection, bone and joint infection, biliary tract infection, abdominal infection, complicated urinary tract infection, skin and soft tissue infection, etc. Since this product is stable to most aminoglycoside inactivating enzymes, it is particularly suitable for the treatment of serious infections caused by Gram-negative bacilli resistant to kanamycin, gentamicin or tobramycin.
Manufacturer:

CSPC OUYI Pharmaceutical Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.